BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 8139712)

  • 1. [Endo-urological drainage in urinary outflow obstruction caused by cancer].
    Stevens A; van Driel MF; Klein JP; de Ruiter AJ; Mensink HJ
    Ned Tijdschr Geneeskd; 1994 Mar; 138(10):522-5. PubMed ID: 8139712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relief of upper urinary tract obstruction in patients with cancer of the prostate].
    Kraemer PC; Borre M
    Ugeskr Laeger; 2009 Mar; 171(11):873-6. PubMed ID: 19278608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of extrinsic malignant ureteral obstruction with urinary diversion.
    Kanou T; Fujiyama C; Nishimura K; Tokuda Y; Uozumi J; Masaki Z
    Int J Urol; 2007 Aug; 14(8):689-92. PubMed ID: 17681056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endourological management of ureteral obstruction after renal transplantation.
    Bosma RJ; van Driel MF; van Son WJ; de Ruiter AJ; Mensink HJ
    J Urol; 1996 Sep; 156(3):1099-100. PubMed ID: 8709316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neoplastic ureteral obstruction: drainage by percutaneous nephrostomy or double J catheterization].
    Desportes L; Blanchet P; Benoît G; Lecouturier S; Langloys J; Decaux A; Di Palma M; Richard C; Jardin A
    Presse Med; 1995 Oct; 24(29):1332-6. PubMed ID: 7494843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Percutaneous placement of a double-J endoprosthesis using a descending approach in malignant pelvic tumor threatening the permeability of the upper urinary tract. Apropos of 10 patients].
    Giron JP; Viville C; Belot G
    J Urol (Paris); 1989; 95(6):331-5. PubMed ID: 2604795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of double "J" ureteral stents in cancerology].
    Dauplat J; Issert B; de Jolinière JB; Dal Soglio I; Giraud B
    Ann Urol (Paris); 1985; 19(4):233-8. PubMed ID: 2411207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstructive uropathy in gynecologic malignancy. Detrimental effect of intraureteral stent placement and value of percutaneous nephrostomy.
    Hyppolite JC; Daniels ID; Friedman EA
    ASAIO J; 1995; 41(3):M318-23. PubMed ID: 8573816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of percutaneous nephrostomy in malignant ureteric obstruction.
    Wilson JR; Urwin GH; Stower MJ
    Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal method of urgent decompression of the collecting system for obstruction and infection due to ureteral calculi.
    Pearle MS; Pierce HL; Miller GL; Summa JA; Mutz JM; Petty BA; Roehrborn CG; Kryger JV; Nakada SY
    J Urol; 1998 Oct; 160(4):1260-4. PubMed ID: 9751331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endoscopic management of bilateral ureteral obstruction after radiotherapy].
    Zeng GH; Li X; Wu KJ; Chen WZ
    Ai Zheng; 2004 Jan; 23(1):108-9. PubMed ID: 14720387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of malignant ureteral obstruction treated with ureteral stents.
    Ganatra AM; Loughlin KR
    J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?
    Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ
    Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endoluminal therapy for bilateral malignant ureteric obstruction].
    Liu YD; Yuan J; Huang ST; Luo JT; Zeng GH; Xun L
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):717-9. PubMed ID: 18246808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endo-urological drainage in urinary outflow obstruction caused by cancer].
    Noordzij JW; Dik P; Zeijlemaker BY; Lock MT; Boon TA
    Ned Tijdschr Geneeskd; 1994 Apr; 138(17):884-5. PubMed ID: 8183410
    [No Abstract]   [Full Text] [Related]  

  • 16. Percutaneous nephrostomy and ureteral stenting in gynecologic malignancies.
    Barton DP; Morse SS; Fiorica JV; Hoffman MS; Roberts WS; Cavanagh D
    Obstet Gynecol; 1992 Nov; 80(5):805-11. PubMed ID: 1407920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urologic emergencies in the cancer patient.
    Russo P
    Semin Oncol; 2000 Jun; 27(3):284-98. PubMed ID: 10864217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
    Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
    J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrostomy in patients with ureteral obstruction secondary to nonurologic malignancy. Obstructive uropathy in malignant disease.
    McNamara TE; Butkus DE
    Arch Intern Med; 1980 Apr; 140(4):494-7. PubMed ID: 7362379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and complications of urinary drainage procedures in idiopathic retroperitoneal fibrosis complicated by extrinsic ureteral obstruction.
    Mertens S; Zeegers AG; Wertheimer PA; Hendriksz TR; van Bommel EF
    Int J Urol; 2014 Mar; 21(3):283-8. PubMed ID: 24033464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.